Linna Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Linna Lu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gang Wang
Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
3 shared publications - Linhua Yang
Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
3 shared publications Lidong Zhao
Second Hospital of Shanxi Medical University, Shanxi, 03001, China
2 shared publicationsShuai Fang
Second Hospital of Shanxi Medical University, Shanxi, 03001, China
2 shared publicationsWukang Shen
Second Hospital of Shanxi Medical University, Shanxi, 03001, China
2 shared publicationsJie Zhang
First Hospital of Shanxi Medical University, Shanxi, 03001, China
1 shared publication
Latest Publications
- Open Access
- 19 February 2024
- Published by Wiley in International Journal of Genomics
- Vol. 2024, 1-8
A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family
Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive genetic disease characterized by clinical symptoms such as eczema, thrombocytopenia with small platelets, immune deficiency, prone to autoimmune diseases, and malignant tumors. This disease is caused by mutations of the WAS gene encoding WASprotein (WASP). The locus and type of mutations of the WAS gene and the expression quantity of WASP were strongly correlated with the clinical manifestations of patients. We found a novel mutation in the WAS gene ( c . 931 + 5 G > C ), which affected splicing to produce three abnormal mRNA, resulting in an abnormally truncated WASP. This mutation led to a reduction but not the elimination of the normal WASP population, resulting in causes X-linked thrombocytopenia (XLT) with mild clinical manifestations. Our findings revealed the pathogenic mechanism of this mutation.
- 19 February 2024
- Published by Wiley in International Journal of Genomics
- Vol. 2024, 1-8
Open AccessA Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family
Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive genetic disease characterized by clinical symptoms such as eczema, thrombocytopenia with small platelets, immune deficiency, prone to autoimmune diseases, and malignant tumors. This disease is caused by mutations of the WAS gene encoding WASprotein (WASP). The locus and type of mutations of the WAS gene and the expression quantity of WASP were strongly correlated with the clinical manifestations of patients. We found a novel mutation in the WAS gene ( c . 931 + 5 G > C ), which affected splicing to produce three abnormal mRNA, resulting in an abnormally truncated WASP. This mutation led to a reduction but not the elimination of the normal WASP population, resulting in causes X-linked thrombocytopenia (XLT) with mild clinical manifestations. Our findings revealed the pathogenic mechanism of this mutation.
- Open Access
- 16 February 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (5)
Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B
Background: Hemophilia B (HB), a rare bleeding disorder, shows X‐linked recessive inheritance and is caused by heterogeneous variants in the FIX gene (F9) encoding coagulation factor IX (FIX). This study aimed to investigate the molecular pathogenesis of a novel Met394Thr variant causing HB.Methods: We used Sanger sequencing to analyze F9 sequence variants in members of a Chinese family with moderate HB. Subsequently, we performed in vitro experiments on the identified novel FIX‐Met394Thr variant. In addition, we performed bioinformatics analysis of the novel variant.Results: We identified a novel missense variant (c.1181T>C, p.Met394Thr) in a Chinese family with moderate HB in the proband. The proband's mother and grandmother were carriers for the variant. The identified FIX‐Met394Thr variant did not affect the transcription of F9 and the synthesis and secretion of FIX protein. The variant may, therefore, affect the physiological function of FIX protein by disrupting its spatial conformation. In addition, another variant (c.88+75A>G) in intron 1 of F9 was identified in the grandmother, which may also affect FIX protein function.Conclusion: We identified FIX‐Met394Thr as a novel causative variant of HB. Further understanding of the molecular pathogenesis underlying FIX deficiency may guide novel strategies for precision HB therapy.
- 16 February 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (5)
Open AccessMolecular pathogenesis of a novel Met394Thr variant causing hemophilia B
Background: Hemophilia B (HB), a rare bleeding disorder, shows X‐linked recessive inheritance and is caused by heterogeneous variants in the FIX gene (F9) encoding coagulation factor IX (FIX). This study aimed to investigate the molecular pathogenesis of a novel Met394Thr variant causing HB.Methods: We used Sanger sequencing to analyze F9 sequence variants in members of a Chinese family with moderate HB. Subsequently, we performed in vitro experiments on the identified novel FIX‐Met394Thr variant. In addition, we performed bioinformatics analysis of the novel variant.Results: We identified a novel missense variant (c.1181T>C, p.Met394Thr) in a Chinese family with moderate HB in the proband. The proband's mother and grandmother were carriers for the variant. The identified FIX‐Met394Thr variant did not affect the transcription of F9 and the synthesis and secretion of FIX protein. The variant may, therefore, affect the physiological function of FIX protein by disrupting its spatial conformation. In addition, another variant (c.88+75A>G) in intron 1 of F9 was identified in the grandmother, which may also affect FIX protein function.Conclusion: We identified FIX‐Met394Thr as a novel causative variant of HB. Further understanding of the molecular pathogenesis underlying FIX deficiency may guide novel strategies for precision HB therapy.
- 27 December 2022
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 45 (3) , E71-E74
Comprehensive analysis of genotypes and phenotypes in 23 Chinese patients with hemophilia B: Identification of five novel variants
- 27 December 2022
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 45 (3) , E71-E74
Comprehensive analysis of genotypes and phenotypes in 23 Chinese patients with hemophilia B: Identification of five novel variants